A loss of c-kit expression is associated with an advanced stage and poor prognosis in breast cancer.
about
Soluble KIT correlates with clinical outcome in patients with metastatic breast cancer treated with sunitinibA phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group Study 0338Quantitative immunohistochemical expression of c Kit in breast carcinomas is predictive of patients' outcome.Columnar cell lesions and pseudoangiomatous hyperplasia like stroma: is there an epithelial-stromal interaction?Triple-negative breast cancer: investigating potential molecular therapeutic target.Sunitinib alone or in combination with chemotherapy for the treatment of advanced breast cancer: A systematic review and meta-analysis.c-KIT receptor expression is strictly associated with the biological behaviour of thyroid nodules.Expression of c-kit protein in cancer vs. normal breast tissue.c-Kit expression as a prognostic molecular marker in patients with basal-like breast cancer.Alterations of oncogenes expression in NK cells in patients with cancer.C-Kit receptor and tryptase expressing mast cells correlate with angiogenesis in breast cancer patients.Associations of epithelial c-kit expression in phyllodes tumours of the breast.Intratumoral CD3+ T-lymphocytes immunoexpression and its association with c-Kit, angiogenesis, and overall survival in malignant canine mammary tumors.C-kit overexpression correlates with KIT gene copy numbers increases in phyllodes tumors of the breast.Expression and Clinical Significance of Claudin-7, PDL-1, PTEN, c-Kit, c-Met, c-Myc, ALK, CK5/6, CK17, p53, EGFR, Ki67, p63 in Triple-negative Breast Cancer-A Single Centre Prospective Observational Study.
P2860
Q36402874-3A06A472-74A0-473A-B308-DAB276D0F36AQ36435548-CDF05C88-C121-4F94-8D8F-958D9DA391F7Q37269650-54D7CDFE-EBA5-4F47-B556-DD73B84E8122Q37418816-A5A57449-F600-4315-97A5-1952FB0F810BQ38259322-100A571D-A7A5-47CC-B909-7608B9DA34D1Q38950248-ECB32391-047C-439E-9B66-3AFBF1570010Q40708235-673C2299-9AB9-4479-B721-F59BDCF3FCB7Q41893560-3C6FA80B-B1EC-44DA-950A-B15B5E1E81FEQ42519332-035BABB3-4DD3-49D1-A88D-7B33DD03A729Q44717067-FD1E20B0-1145-4A86-B424-254315DCE698Q50331415-52D578C5-D75A-4B82-9A16-2031F35CA136Q52937884-552F717A-7A9A-4C07-8FD1-6F0CC277F213Q53354125-F55AEBAB-3D77-4C0D-AFD9-2A04A6B4EAF7Q53660867-1E7BBDCB-37A0-4D93-AE02-7C72F286C641Q55278765-59783659-5AC8-498B-A8F5-F78D793096C2
P2860
A loss of c-kit expression is associated with an advanced stage and poor prognosis in breast cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
A loss of c-kit expression is ...... or prognosis in breast cancer.
@ast
A loss of c-kit expression is ...... or prognosis in breast cancer.
@en
type
label
A loss of c-kit expression is ...... or prognosis in breast cancer.
@ast
A loss of c-kit expression is ...... or prognosis in breast cancer.
@en
prefLabel
A loss of c-kit expression is ...... or prognosis in breast cancer.
@ast
A loss of c-kit expression is ...... or prognosis in breast cancer.
@en
P2093
P2860
P356
P1476
A loss of c-kit expression is ...... or prognosis in breast cancer.
@en
P2093
H Takeuchi
T Nishizaki
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603183
P407
P577
2006-05-23T00:00:00Z